Anti-Flt-1 antibodies for treating duchenne muscular dystrophy

The present invention provides, among other things, anti-Flt-1 antibodies and methods for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: De Haard, Hans, Keefe, Dennis, Gabriels, Sofie, De Jonge, Natalie
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator De Haard, Hans
Keefe, Dennis
Gabriels, Sofie
De Jonge, Natalie
description The present invention provides, among other things, anti-Flt-1 antibodies and methods for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to DMD an effective amount of an anti-Flt-1 antibody or antigen-binding protein thereof such that at least one symptom or feature of DMD is reduced in intensity, severity, or frequency, or has delayed onset.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2016246722A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2016246722A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2016246722A13</originalsourceid><addsrcrecordid>eNrjZLBzzCvJ1HXLKdE1VEgEMpPyUzJTixXS8osUSopSE0sy89IVUkqTM1Lz8lIVckuLk0tzEosUUiqLS4ryCzIqeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvGOokYGhmZGJmbmRkaOhMXGqAAC2MWU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anti-Flt-1 antibodies for treating duchenne muscular dystrophy</title><source>esp@cenet</source><creator>De Haard, Hans ; Keefe, Dennis ; Gabriels, Sofie ; De Jonge, Natalie</creator><creatorcontrib>De Haard, Hans ; Keefe, Dennis ; Gabriels, Sofie ; De Jonge, Natalie</creatorcontrib><description>The present invention provides, among other things, anti-Flt-1 antibodies and methods for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to DMD an effective amount of an anti-Flt-1 antibody or antigen-binding protein thereof such that at least one symptom or feature of DMD is reduced in intensity, severity, or frequency, or has delayed onset.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171026&amp;DB=EPODOC&amp;CC=AU&amp;NR=2016246722A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171026&amp;DB=EPODOC&amp;CC=AU&amp;NR=2016246722A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>De Haard, Hans</creatorcontrib><creatorcontrib>Keefe, Dennis</creatorcontrib><creatorcontrib>Gabriels, Sofie</creatorcontrib><creatorcontrib>De Jonge, Natalie</creatorcontrib><title>Anti-Flt-1 antibodies for treating duchenne muscular dystrophy</title><description>The present invention provides, among other things, anti-Flt-1 antibodies and methods for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to DMD an effective amount of an anti-Flt-1 antibody or antigen-binding protein thereof such that at least one symptom or feature of DMD is reduced in intensity, severity, or frequency, or has delayed onset.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBzzCvJ1HXLKdE1VEgEMpPyUzJTixXS8osUSopSE0sy89IVUkqTM1Lz8lIVckuLk0tzEosUUiqLS4ryCzIqeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvGOokYGhmZGJmbmRkaOhMXGqAAC2MWU</recordid><startdate>20171026</startdate><enddate>20171026</enddate><creator>De Haard, Hans</creator><creator>Keefe, Dennis</creator><creator>Gabriels, Sofie</creator><creator>De Jonge, Natalie</creator><scope>EVB</scope></search><sort><creationdate>20171026</creationdate><title>Anti-Flt-1 antibodies for treating duchenne muscular dystrophy</title><author>De Haard, Hans ; Keefe, Dennis ; Gabriels, Sofie ; De Jonge, Natalie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2016246722A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>De Haard, Hans</creatorcontrib><creatorcontrib>Keefe, Dennis</creatorcontrib><creatorcontrib>Gabriels, Sofie</creatorcontrib><creatorcontrib>De Jonge, Natalie</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>De Haard, Hans</au><au>Keefe, Dennis</au><au>Gabriels, Sofie</au><au>De Jonge, Natalie</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anti-Flt-1 antibodies for treating duchenne muscular dystrophy</title><date>2017-10-26</date><risdate>2017</risdate><abstract>The present invention provides, among other things, anti-Flt-1 antibodies and methods for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to DMD an effective amount of an anti-Flt-1 antibody or antigen-binding protein thereof such that at least one symptom or feature of DMD is reduced in intensity, severity, or frequency, or has delayed onset.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2016246722A1
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title Anti-Flt-1 antibodies for treating duchenne muscular dystrophy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T07%3A45%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=De%20Haard,%20Hans&rft.date=2017-10-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2016246722A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true